The VBU continues to crumble

[anonymous]

Not lonely at all, your mom keeps great company.

There’s nothing like a lonely late night post

 

[anonymous]

There’s nothing like a lonely late night post

Not lonely at all, your mom keeps great company!

 

[anonymous]

Not lonely at all, your mom keeps great company!

There’s nothing like a lonely late night post

 

[anonymous]

There’s nothing like a lonely late night post

I think I count three things.

 

[anonymous]

Given the recent implementation of our new reorganization in the VBU, Do you feel better than you did one year ago?

 

[anonymous]

Given the recent implementation of our new reorganization in the VBU, Do you feel better than you did one year ago?

no

 

[anonymous]

it seems like more of the good folks from HQ marketing are leaving! Why?

 

[anonymous]

it seems like more of the good folks from HQ marketing are leaving! Why?

The underperformance of Arexvy, which achieved sales far below consensus estimates is a good reason to leave. You can have the best marketers in the world but given the handcuffs the FDA slapped on indications and competition in the market place Arexvy is dragging down the expectations for the VBU.

 

[anonymous]

The underperformance of Arexvy, which achieved sales far below consensus estimates is a good reason to leave. You can have the best marketers in the world but given the handcuffs the FDA slapped on indications and competition in the market place Arexvy is dragging down the expectations for the VBU.

Lol!!! You are so completely out of touch with the performance of this vaccine!

 

[anonymous]

Lol!!! You are so completely out of touch with the performance of this vaccine!

Ya drinking the juice snow flake.

 

[anonymous]

Ya drinking the juice snow flake.

No just basic public fucking knowledge

 

[anonymous]

Ya drinking the juice snow flake.

Go annoy Pfizer, you are confused.

 

[anonymous]

Lol!!! You are so completely out of touch with the performance of this vaccine!

The performance of Arexvy was above expectations this year. Unfortunately, that time has passed. The new restrictions are a reality that corporate doesn’t want to acknowledge or face. We were lucky to get that 15,000 payout earlier this year. It is what it is.

 

[anonymous]

The performance of Arexvy was above expectations this year. Unfortunately, that time has passed. The new restrictions are a reality that corporate doesn’t want to acknowledge or face. We were lucky to get that 15,000 payout earlier this year. It is what it is.

RSV vaccine market to decline 64% on CDC decision: report

 

[anonymous]

RSV vaccine market to decline 64% on CDC decision: report

We just need to get most the RSV pie to make up for the tight guidelines to grow sales.

 

[anonymous]

RSV vaccine market to decline 64% on CDC decision: report

Reality. But corporate will pin declining sales on the sales force. It’s what they do all day every day. Not just at GSK, but everywhere in pharma. Accountability is a one way street in this industry.

 

[anonymous]

We just need to get most the RSV pie to make up for the tight guidelines to grow sales.

Less bonus or lesser bonus, this is the best gig a sales rep could have in the VBU. Thank you GSK

 

[anonymous]

https://www.reuters.com/business/he...ises-annual-sales-profit-forecast-2024-07-31/

 

[anonymous]

https://www.reuters.com/business/he...ises-annual-sales-profit-forecast-2024-07-31/

Good luck with ya all in the VBU. Hope you saved your past bonus checks. The screws will be put to you in a no win situation. Why do you think marketing left. Bend over, your only choice is to leave.

 

[anonymous]

Currently, who are considered the best FLL's and RVP's in the U.S. sales market? What about the worst nightmares?